Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Rapid Response Innovation Awards, 2011
    Developing a Human Neural Model for Parkinson's Disease

    Objective/Rationale: 
    Advances in the knowledge and treatment of Parkinson’s disease (PD) are limited by the inability to obtain, grow and study neural cells from the brains of living patients. Small...

  • MJFF Research Grant, 2011
    Development and Test of a P25a Competitive Alpha-synuclein Aggregate Binding Assay and Test of Thioflavin-T as Competitor

    Objective/Rationale: 
    Compounds targeting aggregated alpha-synuclein are high in demand as potential bio-imaging tools. We have previously developed an assay that measures the binding of the protein...

  • MJFF Research Grant, 2011
    Just in Time Pre-clinical Resource for Evaluating Symptoms & Side Effects and/or Dyskinesia Treatments

    Objective/Rationale:
    There is a clear need for the development of novel treatments to better manage the symptoms of Parkinson’s disease. While current treatments address some of the motor symptoms of...

  • MJFF Research Grant, 2011
    Generation of Synthetic Alpha-synuclein for the PD Research Community

    Objective/Rationale:
    Despite increasing evidence linking specific modifications to alpha-synuclein (alpha-syn), alpha-synuclein aggregation, and Lewy body (LB) formation, little is still known...

  • LRRK2 Target Engagement Ligand, 2011
    Discovery of LRRK2 Target Engagement Ligands to be Used in Imaging Studies

    Objective/Rationale: 
    LRRK2 is an emerging target for discovery of a neuroprotective agent for treatment of PD. Multiple mutations within the LRRK2 gene are associated with PD and many of these have...

  • LRRK2 Target Engagement Ligand, 2011
    LRRK2 Target Engagement Ligand

    Objective/Rationale: 
    Target engagement ligands, also known as imaging agents, are useful tools in the development of drugs and this project seeks to develop such a tool for Leucine Rich Repeat Kinase...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.